2m 2m 2m 2m 2m 2m 2m
GT Biopharma (GTBP)
NASDAQ
$5.49-$0.03 (-0.63%)
Price as of Oct 22, 2026 7:30 PM EDT- $11.2MMarket Cap
- -67.74%1-Year Change
- BiotechnologyIndustry
GT Biopharma (GTBP)
$5.49-$0.03 (-0.63%)
GTBP | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $5.52 | ||
Change | -$1.90 (-25.99%) | ||
Open | $5.37 | ||
High | $5.57 | ||
Low | $5.28 | ||
Previous Close | $5.41 | ||
Volume | 69,418 | ||
30-Day Average Volume | 49,127 | ||
1-Week Change | -12.88% | ||
1-Month Change | -24.65% | ||
1-Year Change | -67.74% | ||
3-Year Change | -97.16% | ||
5-Year Change | -99.89% | ||
Fundamentals | |||
Shares Outstanding | 2.1M | ||
Total Assets | $5.8M | ||
Market Cap | $11.2M | ||
Enterprise Value | $6.2M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$4.6M | ||
Free Cash Flow | -$4.3M | ||
EBIT | -$4.6M | ||
EBITDA | -$4.6M | ||
Net Working Capital | $3.6M | ||
EPS | -$3.00 | ||
Enterprise Value/EBITDA | -1 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 6 | ||
P/E | -2 | ||
PEG | 0 | ||
Price/Free Cash Flow | -3 | ||
Price/Operating Cash Flow | -3 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 25 | ||
Last Split Date | 09/08/2026 | ||
Earnings & Revenue